Cargando…
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to Aspergillus species that aggravates bronchial asthma. Previous studies demonstrated the glucocorticoid-sparing effect of dupilumab in patients with ABPA. There is no report of complete withdrawal of glucocorticoids...
Autores principales: | Nishimura, Tadashi, Okano, Tomohito, Naito, Masahiro, Tsuji, Chikashi, Iwanaka, Soichi, Sakakura, Yasumasa, Yasuma, Taro, Fujimoto, Hajime, D'Alessandro-Gabazza, Corina N, Oomoto, Yasuhiro, Kobayashi, Tetsu, Gabazza, Esteban C, Ibata, Hidenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362523/ https://www.ncbi.nlm.nih.gov/pubmed/34447843 http://dx.doi.org/10.12998/wjcc.v9.i23.6922 |
Ejemplares similares
-
Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?
por: Nishimura, Tadashi, et al.
Publicado: (2022) -
Second‐line therapy with first‐ or second‐generation tyrosine kinase inhibitors in EGFR‐mutated non‐small cell lung cancer patients with T790M‐negative or unidentified mutation
por: Nishimura, Tadashi, et al.
Publicado: (2021) -
Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma
por: Nishimura, Tadashi, et al.
Publicado: (2023) -
No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021) -
Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Yasuma, Taro, et al.
Publicado: (2021)